Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cytokinetics (CYTK)

Cytokinetics (CYTK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,080,795
  • Shares Outstanding, K 83,513
  • Annual Sales, $ 55,830 K
  • Annual Income, $ -127,290 K
  • 60-Month Beta 1.31
  • Price/Sales 57.04
  • Price/Cash Flow N/A
  • Price/Book 165.89
Trade CYTK with:

Options Overview Details

View History
  • Implied Volatility 72.08%
  • Historical Volatility 52.59%
  • IV Percentile 23%
  • IV Rank 16.72%
  • IV High 185.10% on 07/08/21
  • IV Low 49.39% on 08/31/21
  • Put/Call Vol Ratio 0.17
  • Today's Volume 179
  • Volume Avg (30-Day) 430
  • Put/Call OI Ratio 0.05
  • Today's Open Interest 4,172
  • Open Int (30-Day) 2,909

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.75
  • Number of Estimates 5
  • High Estimate -0.72
  • Low Estimate -0.77
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -1,400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.99 +15.32%
on 09/20/21
39.46 -6.51%
on 10/07/21
+3.19 (+9.47%)
since 09/15/21
3-Month
19.04 +93.75%
on 07/16/21
39.46 -6.51%
on 10/07/21
+17.57 (+90.94%)
since 07/15/21
52-Week
14.89 +147.75%
on 10/29/20
39.46 -6.51%
on 10/07/21
+20.66 (+127.30%)
since 10/15/20

Most Recent Stories

More News
How Much Upside is Left in Cytokinetics (CYTK)? Wall Street Analysts Think 37%

The average of price targets set by Wall Street analysts indicates a potential upside of 36.8% in Cytokinetics (CYTK). While the effectiveness of this highly sought-after metric is questionable, the positive...

CYTK : 36.89 (-3.25%)
Cytokinetics Outlines Go-To-Market Strategy for Omecamtiv Mecarbil and Provides Updates on Cardiovascular Pipeline at Today’s Analyst & Investor Day

Go-To-Market Strategy Focuses on Educating Healthcare Professionals, Ensuring Managed Care Access, and Enacting Programs for Patient Access, Education and...

CYTK : 36.89 (-3.25%)
Zoom, Royal Caribbean fall; Cytokinetics, SPX Flow rise

Stocks that traded heavily or had substantial price changes Monday:

ZM : 266.32 (-0.26%)
CYTK : 36.89 (-3.25%)
RCL : 86.32 (-0.67%)
SIX : 43.70 (-0.34%)
CALM : 35.05 (+1.27%)
FLOW : 73.13 (-0.11%)
Cracker Barrel, Sage Therapeutics fall; Ocugen, FedEx rise

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Tuesday:

FDX : 229.12 (+0.73%)
CBRL : 134.69 (-2.14%)
CYTK : 36.89 (-3.25%)
SAGE : 44.94 (-2.07%)
TROW : 199.76 (+1.19%)
Coty, Eaton Vance rise; Domino's, Cytokinetics fall

NEW YORK (AP) — Stocks that moved heavily or traded substantially Thursday:

CYTK : 36.89 (-3.25%)
PPG : 160.30 (+0.89%)
MS : 102.14 (+1.12%)
IBM : 144.61 (+0.85%)
AMGN : 207.84 (+0.51%)
COTY : 7.83 (-0.38%)
EV : 73.07 (-0.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or deteriorating. With an unmatched understanding of muscle biology...

See More

Key Turning Points

3rd Resistance Point 40.52
2nd Resistance Point 39.74
1st Resistance Point 38.32
Last Price 36.89
1st Support Level 36.12
2nd Support Level 35.34
3rd Support Level 33.92

See More

52-Week High 39.46
Last Price 36.89
Fibonacci 61.8% 30.07
Fibonacci 50% 27.18
Fibonacci 38.2% 24.28
52-Week Low 14.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar